<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AAnticholinergic_Toxicity_Treatement%2Fen</id>
	<title>Template:Anticholinergic Toxicity Treatement/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AAnticholinergic_Toxicity_Treatement%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Anticholinergic_Toxicity_Treatement/en&amp;action=history"/>
	<updated>2026-04-20T13:02:05Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Anticholinergic_Toxicity_Treatement/en&amp;diff=383785&amp;oldid=prev</id>
		<title>FuzzyBot: Updating to match new version of source page</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Anticholinergic_Toxicity_Treatement/en&amp;diff=383785&amp;oldid=prev"/>
		<updated>2026-01-23T09:23:35Z</updated>

		<summary type="html">&lt;p&gt;Updating to match new version of source page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;&amp;lt;languages/&amp;gt;&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
*Consider GI decon with [[Special:MyLanguage/Activated Charcoal|Activated Charcoal]] if patient presents &amp;lt;2 hours after ingestion and remains cooperative&lt;br /&gt;
&lt;br /&gt;
===Sedation===&lt;br /&gt;
&lt;br /&gt;
*Decreases the risk of [[Special:MyLanguage/hyperthermia|hyperthermia]], [[Special:MyLanguage/rhabdo|rhabdo]], traumatic injuries&lt;br /&gt;
*[[Special:MyLanguage/Benzos|Benzos]] are agents of choice especially increase seizure threshold&amp;lt;ref&amp;gt;Burns MJ, et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000:35(4):374-381.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Repeat boluses every 5-15 minutes as needed to halt seizures and provide adequate sedation&lt;br /&gt;
**Goal: QRS duration &amp;lt; 110 msec&lt;br /&gt;
&lt;br /&gt;
===Cholinesterase inhibition===&lt;br /&gt;
&lt;br /&gt;
*Indicated for severe agitation or delirium (esp if unresponsive to [[Special:MyLanguage/benzos|benzos]])&lt;br /&gt;
*Contraindicated in QRS&amp;gt;100 or Na blockade signs (R' in aVR) and in narrow angle glaucoma&lt;br /&gt;
*Relatively contraindicated in asthma or ileus&lt;br /&gt;
*[[Special:MyLanguage/Physostigmine|Physostigmine]] - strongly consider poison control consult before giving&lt;br /&gt;
**Crosses blood brain barrier, can be used to help make dx&lt;br /&gt;
**Dosing: 0.5mg-1mg IV over 5min (repeat dosing up to 2mg in first hour)&amp;lt;ref&amp;gt;Rosenbaum C and Bird SB. Timing and frequency for physostigmine redosing for antimuscarininc toxicity. J Med Toxicol. 2010;6:386-92.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Onset of action: 5-10min&lt;br /&gt;
**If partial response, repeat x3&lt;br /&gt;
**If 3 or more administrations are needed over a 6-hour period, start IV infusion (bolus 1-2 mg followed by 1 mg/hour)&lt;br /&gt;
**Stop infusion every 12 hours to determine resolution of the toxidrome&lt;br /&gt;
**Side effects: bradycardia, dysrhythmias, cholinergic excess&amp;lt;ref&amp;gt;Pentel P and Peterson CD. Aystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980 Nov;9(11):588-90.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Always have [[Special:MyLanguage/atropine|atropine]] at the bedside for bradycardia or cholinergic excess&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Nguyen TT, et al. Adverse events from physostigmine: an observational study. Am J Emerg Med. 2018;36:141-2.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**'''Contraindicated''' in [[Special:MyLanguage/TCA toxicity|TCA toxicity]] (associated with cardiac arrest) and in the presence of bradycardia or AV block&lt;br /&gt;
&lt;br /&gt;
===Other therapies===&lt;br /&gt;
&lt;br /&gt;
*[[Special:MyLanguage/Sodium bicarbonate|Sodium bicarbonate]] for conduction abnormalities (QRS prolongation)&lt;br /&gt;
**2 mEq/kg bolus (typically 2-3 amps of bicarb)&lt;br /&gt;
**Begin continuous NaCO3 infusion at 250mL/hr if bolus effective  &lt;br /&gt;
**Solution preparation = 1L D5W mixed with 3 ampules NaHCO3&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>